This federal contract award, valued at $2,365.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566669347 - ROPIVACAINE 0.2% 400 MG/200 ML 200ML, a pharmaceutical product. The contract has an ultimate completion date of December 11, 2024 and was awarded on December 10, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The DLA IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not utilize any set-aside designations, indicating open competition.
Generated 3/11/25, 9:54 AM